Published in Diabetes Res Clin Pract on January 01, 1991
Fetal Hox11 expression patterns predict defective target organs: a novel link between developmental biology and autoimmunity. Immunol Cell Biol (2008) 1.51
Risk factors for hearing impairment among U.S. adults with diabetes: National Health and Nutrition Examination Survey 1999-2004. Diabetes Care (2011) 1.04
Early sensorineural hearing loss in ob/ob mouse, an animal model of type 2 diabetes. Clin Exp Otorhinolaryngol (2008) 0.88
Interactions of hearing loss and diabetes mellitus in the middle age CBA/CaJ mouse model of presbycusis. Hear Res (2009) 0.88
The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's syndrome. Lab Invest (2013) 0.87
A clinical study of audiological profile in diabetes mellitus patients. Eur Arch Otorhinolaryngol (2012) 0.82
Evaluation of hearing loss in juvenile insulin dependent patients with diabetes mellitus. J Res Med Sci (2011) 0.75
Is type 1 diabetes mellitus a cause for subtle hearing loss in pediatric patients? Eur Arch Otorhinolaryngol (2014) 0.75
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med (2001) 10.36
Complications of hysteroscopic Essure(®) sterilisation: report on 4306 procedures performed in a single centre. BJOG (2012) 2.16
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia (2011) 1.94
Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia (2002) 1.93
Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med (2006) 1.84
Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol (1994) 1.60
Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data. Diabetologia (2004) 1.57
Deleterious effect of dithizone-DMSO staining on insulin secretion in rat and human pancreatic islets. Pancreas (1994) 1.45
Acute epiglottitis in the adult. J Laryngol Otol (1991) 1.44
Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol Cell Biol (2001) 1.39
Calcium elevation in mouse pancreatic beta cells evoked by extracellular human islet amyloid polypeptide involves activation of the mechanosensitive ion channel TRPV4. Diabetologia (2008) 1.14
Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin Exp Immunol (2003) 1.13
Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes. Diabetes Care (2000) 1.12
Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels. J Clin Endocrinol Metab (1983) 1.10
4-Hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties. Am J Physiol (1999) 1.09
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol. Diabetologia (2005) 1.09
The 1997 ADA diabetes diagnostic categories: impact on employees' annual medical examination. Diabet Med (1999) 1.08
Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control. Diabetes Res Clin Pract (2006) 1.08
Rosiglitazone RECORD study: glucose control outcomes at 18 months. Diabet Med (2007) 1.08
Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol (1996) 1.07
4-Hydroxyisoleucine: a novel amino acid potentiator of insulin secretion. Diabetes (1998) 1.07
Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes (1999) 1.06
Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1994) 1.01
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients. Diabet Med (2000) 1.00
Antioxidant activity and radioprotective effects against chromosomal damage induced in vivo by X-rays of flavan-3-ols (Procyanidins) from grape seeds (Vitis vinifera): comparative study versus other phenolic and organic compounds. J Agric Food Chem (2000) 0.98
Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial. Diabetes Obes Metab (2008) 0.97
P2 receptor agonists stimulate insulin release from human pancreatic islets. Pancreas (2001) 0.97
Expression of GLUT-2 antisense RNA in beta cells of transgenic mice leads to diabetes. J Biol Chem (1994) 0.97
Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM. Diabetes (1995) 0.97
Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. Lupus (2008) 0.96
Radioprotective effects in vivo of phenolics extracted from Olea europaea L. leaves against X-ray-induced chromosomal damage: comparative study versus several flavonoids and sulfur-containing compounds. J Med Food (2002) 0.96
Radioprotective-antimutagenic effects of rosemary phenolics against chromosomal damage induced in human lymphocytes by gamma-rays. J Agric Food Chem (2006) 0.95
Symptomatic and hormonal hypoglycaemic responses to human and porcine insulin in patients with type I diabetes mellitus. Diabet Med (1992) 0.94
The role of transmembrane protein 27 (TMEM27) in islet physiology and its potential use as a beta cell mass biomarker. Diabetologia (2010) 0.94
White coat hypertension in type 1 diabetic patients without nephropathy. Am J Hypertens (2000) 0.93
Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia (2001) 0.93
Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucose. Diabet Med (2003) 0.93
Effects of single dose irradiation on pancreatic beta-cell function. Radiother Oncol (1991) 0.92
Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications. Diabetes Metab (2004) 0.92
Critical assessment of the current guidelines for the management and treatment of morbidly obese patients. J Endocrinol Invest (2007) 0.92
Regulation of islet amyloid polypeptide in human pancreatic islets. Diabetes (1993) 0.91
Reevaluation of autoantibodies to islet cell membrane in IDDM. Failure to detect islet cell surface antibodies using human islet cells as substrate. Diabetes (1992) 0.91
Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes. Mol Cell Endocrinol (2001) 0.91
Effects of tungstate in neonatally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycaemia. Diabetologia (1997) 0.91
Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responses. J Thromb Haemost (2011) 0.90
A high carbohydrate diet does not induce hyperglycaemia in a mitochondrial glycerol-3-phosphate dehydrogenase-deficient mouse. Diabetologia (2003) 0.90
Renal hemodynamic abnormalities in patients with short term insulin-dependent diabetes mellitus: role of renal prostaglandins. J Clin Endocrinol Metab (1985) 0.89
Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia. Int J Clin Pract (2008) 0.88
Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study. Diabetes (1989) 0.88
Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats. Diabetes (2001) 0.88
[Blood pressure self measurement: Spanish consensus document]. Nefrologia (2007) 0.87
Cigarette smoke concentrate increases 8-epi-PGF2alpha and TGFbeta1 secretion in rat mesangial cells. Life Sci (2004) 0.87
Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study. Diabetologia (2001) 0.87
Effects of thromboxane synthesis inhibitor triflusal on renal hemodynamics in microalbuminuric diabetic patients. Diabetes Care (1990) 0.87
Signals derived from glucose metabolism are required for glucose regulation of pancreatic islet GLUT2 mRNA and protein. Diabetes (1993) 0.87
The role of Raf-1 kinase inhibitor protein in the regulation of pancreatic beta cell proliferation in mice. Diabetologia (2012) 0.86
Type 2 diabetes--treat early, treat intensively. Int J Clin Pract Suppl (2007) 0.86
Transglutaminase activity in pancreatic islets. Biochim Biophys Acta (1983) 0.86
Hearing and diabetes. ORL J Otorhinolaryngol Relat Spec (1996) 0.86
Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas. Diabetes (1999) 0.85
Role of spontaneous portal-systemic shunting in hyperinsulinism of cirrhosis. Am J Physiol (1984) 0.85
Diabetes mellitus in patients with liver cirrhosis. Diabetes Res Clin Pract (1994) 0.84
Role of transglutaminase in insulin release. Study with glycine and sarcosine methylesters. Endocrinology (1985) 0.84
F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control. Metabolism (2004) 0.84
Initiation of insulin glargine in suboptimally controlled patients with type 2 diabetes: sub-analysis of the AT.LANTUS trial comparing treatment outcomes in subjects from primary and secondary care in the UK. Diabetes Obes Metab (2007) 0.84
Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families. Eur J Endocrinol (2000) 0.84
Differential activity of nitric oxide synthase in human nasal mucosa and polyps. Eur Respir J (1996) 0.83
A novel mutation in islet amyloid polypeptide (IAPP) gene promoter is associated with Type II diabetes mellitus. Diabetologia (2001) 0.83
High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients. A study in Catalonia, a mediterranean community. Diabetes Res Clin Pract (1998) 0.83
Immunocytochemical study of pancreatic islet revascularization in islet isograft. Effect of hyperglycemia of the recipient and of in vitro culture of islets. Transplantation (1994) 0.83
High glucose concentration favors the selective secretion of islet amyloid polypeptide through a constitutive secretory pathway in human pancreatic islets. Pancreas (2001) 0.83
Human insulin-induced lipoatrophy. Successful treatment using a jet-injection device. Diabetes Care (1996) 0.82
Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients. Diabetologia (1989) 0.82
Role of thyroid hormones on serum leptin levels. Eur J Endocrinol (1998) 0.82
Proof-of-concept trial on the efficacy of sodium tungstate in human obesity. Diabetes Obes Metab (2010) 0.82
[The inguinal pedicle flap in emergency traumatic hand surgery: value of the long pedicle permitting an early rehabilitation]. Ann Chir Main Memb Super (1991) 0.82
[Prevalence and clinical aspects of cardiovascular vegetative neuropathy in a diabetic population]. Med Clin (Barc) (1985) 0.82
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes]. Ugeskr Laeger (2001) 0.81
Prevalence of islet cell antibodies, insulin antibodies and hyperglycaemia in 2291 schoolchildren. Diabetologia (1987) 0.81
Smoking increases serum levels of transforming growth factor-beta in diabetic patients. Diabetes Care (1999) 0.81
Effects of several flavonoids on the growth of B16F10 and SK-MEL-1 melanoma cell lines: relationship between structure and activity. Melanoma Res (2002) 0.81
Mediterranean diet adherence in individuals with prediabetes and unknown diabetes: the Di@bet.es Study. Ann Nutr Metab (2013) 0.81
Mutation in the calcium-binding domain of the mitochondrial glycerophosphate dehydrogenase gene in a family of diabetic subjects. Biochem Biophys Res Commun (1997) 0.81
Reg genes are CCK2 receptor targets in ElasCCK2 mice pancreas. Regul Pept (2007) 0.81
High-monounsaturated fat, olive oil-rich diet has effects similar to a high-carbohydrate diet on fasting and postprandial state and metabolic profiles of patients with type 2 diabetes. Metabolism (2000) 0.81
Congenital pseudarthrosis of the forearm-two cases treated by free vascularized fibular graft. J Hand Surg Am (1981) 0.81
Amylin effect in extrapancreatic tissues participating in glucose homeostasis, in normal, insulin-resistant and type 2 diabetic state. Peptides (2011) 0.81
Increased CD5-positive B lymphocytes in type I diabetes. Clin Exp Immunol (1991) 0.80
Comparison of models used for UV index calculations. Photochem Photobiol (1998) 0.80
Sodium tungstate regulates food intake and body weight through activation of the hypothalamic leptin pathway. Diabetes Obes Metab (2011) 0.80
Functional properties of isolated human pancreatic islets beneficial effects of culture and exposure to high glucose concentrations. Diabete Metab (1995) 0.80
Glucose and fructose as functional modulators of overall dog, but not boar sperm function. Reprod Fertil Dev (2011) 0.80